Reardon Tighe
CIK: 0001760431•Acting Chief Financial Officer
Officer
Primary company: Janux Therapeutics, Inc. (JANX)
Reardon Tighe is a corporate insider (Acting Chief Financial Officer) at Janux Therapeutics, Inc. (JANX) filing SEC Form 4 transactions. 19 transactions across 2 companies, totaling $21,688,635 in purchases and $45,043,975 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Sale | 691,525 | $54.75 | $37.86M | 3,340,018 | 6/3/2024 Filed: 6/5/2024 | Filing → | |
| Sale | 131,196 | $54.75 | $7.18M | 633,673 | 6/3/2024 Filed: 6/5/2024 | Filing → | |
| Award | 157,000 | - | - | 157,000 | 1/2/2024 Filed: 1/3/2024 | Filing → | |
| Purchase | 849,854 | $5.87 | $4.99M | 849,854 | 11/13/2023 Filed: 11/15/2023 | Filing → | |
| Award | 110,000 | $0.00 | $0 | 110,000 | 1/3/2023 Filed: 1/5/2023 | Filing → | |
| Award | 116,750 | $0.00 | $0 | 116,750 | 1/3/2022 Filed: 1/5/2022 | Filing → | |
| Conversion | 900,264 | - | - | 0 | 6/15/2021 Filed: 6/16/2021 | Filing → | |
| Conversion | 2,105,264 | - | - | 0 | 6/15/2021 Filed: 6/16/2021 | Filing → | |
| Purchase | 629,411 | $17.00 | $10.70M | 4,479,492 | 6/15/2021 Filed: 6/16/2021 | Filing → | |
| Conversion | 1,153,238 | - | - | 3,850,081 | 6/15/2021 Filed: 6/16/2021 | Filing → | |
| Conversion | 2,696,843 | - | - | 2,696,843 | 6/15/2021 Filed: 6/16/2021 | Filing → | |
Synthorx, Inc. THOR | Disposition | 30,000 | $57.00 | $1.71M | 0 | 1/23/2020 Filed: 1/24/2020 | Filing → |
Synthorx, Inc. THOR | Disposition | 18,723 | $63.36 | $1.19M | 0 | 1/23/2020 Filed: 1/24/2020 | Filing → |
Synthorx, Inc. THOR | U | 1,682,086 | $68.00 | $114.38M | 0 | 1/23/2020 Filed: 1/24/2020 | Filing → |
Synthorx, Inc. THOR | U | 43,688 | $68.00 | $2.97M | 0 | 1/23/2020 Filed: 1/24/2020 | Filing → |
Synthorx, Inc. THOR | Conversion | 1,821,156 | $0.00 | $0 | 0 | 12/11/2018 Filed: 12/13/2018 | Filing → |
Synthorx, Inc. THOR | Purchase | 545,455 | $11.00 | $6.00M | 1,682,086 | 12/11/2018 Filed: 12/13/2018 | Filing → |
Synthorx, Inc. THOR | Conversion | 1,136,631 | - | - | 1,136,631 | 12/11/2018 Filed: 12/13/2018 | Filing → |
Synthorx, Inc. THOR | Award | 30,000 | $0.00 | $0 | 30,000 | 12/6/2018 Filed: 12/7/2018 | Filing → |
Type
Sale
Shares
691,525
Price
$54.75
Value
$37.86M
Type
Sale
Shares
131,196
Price
$54.75
Value
$7.18M
Type
Award
Shares
157,000
Price
-
Value
-
Type
Purchase
Shares
849,854
Price
$5.87
Value
$4.99M
Type
Award
Shares
110,000
Price
$0.00
Value
$0
Type
Award
Shares
116,750
Price
$0.00
Value
$0
Type
Conversion
Shares
900,264
Price
-
Value
-
Type
Conversion
Shares
2,105,264
Price
-
Value
-
Type
Purchase
Shares
629,411
Price
$17.00
Value
$10.70M
Type
Conversion
Shares
1,153,238
Price
-
Value
-
Type
Conversion
Shares
2,696,843
Price
-
Value
-
Synthorx, Inc.
THOR
Type
Disposition
Shares
30,000
Price
$57.00
Value
$1.71M
Synthorx, Inc.
THOR
Type
Disposition
Shares
18,723
Price
$63.36
Value
$1.19M
Synthorx, Inc.
THOR
Type
U
Shares
1,682,086
Price
$68.00
Value
$114.38M
Synthorx, Inc.
THOR
Type
U
Shares
43,688
Price
$68.00
Value
$2.97M
Synthorx, Inc.
THOR
Type
Conversion
Shares
1,821,156
Price
$0.00
Value
$0
Synthorx, Inc.
THOR
Type
Purchase
Shares
545,455
Price
$11.00
Value
$6.00M
Synthorx, Inc.
THOR
Type
Conversion
Shares
1,136,631
Price
-
Value
-
Synthorx, Inc.
THOR
Type
Award
Shares
30,000
Price
$0.00
Value
$0
AI Agent
Try asking...